Vcreate
1 known investors
Find your way into Vcreate
1,218 people in our graph share verified history with the Vcreate team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Ethan Fast · together at Stanford University (overlapped)
×9knows the team · via Stanford University
×2knows the team · via Y Combinator
Vcreate uses machine learning and single-cell sequencing screening assays to engineer human T-cell receptors (TCRs) for TCR-based therapies that target disease-specific antigens, including rare cancer mutations. Its platform screens hundreds of millions of TCR-antigen interactions to design receptors that activate against targets inside cells that are otherwise difficult to drug.
Founders & leadership
EF
Ethan FastinCo-Founder and CTOEthan Fast holds a PhD in Computer Science from Stanford with research spanning human-computer interaction, machine learning, and programming languages. He has focused on immunology and machine learning applications, including TCR-antigen interaction prediction and MHC antigen presentation modeling, and is founder of Vcreate, which engineers T-cell receptors for cancer and other diseases.
Investors · 1
Founder mafia
2 people who came through Vcreate went on to found or lead other companies.
Frequently asked questions
- What does Vcreate do?
- Vcreate uses machine learning and single-cell sequencing screening assays to engineer human T-cell receptors (TCRs) for TCR-based therapies that target disease-specific antigens, including rare cancer mutations. Its platform screens hundreds of millions of TCR-antigen interactions to design receptors that activate against targets inside cells that are otherwise difficult to drug.
- Who founded Vcreate?
- Vcreate was founded by Ethan Fast.
- Who are Vcreate's investors?
- Vcreate's investors include Fifty Years.